Cold Spring Harbor, 454 Life Sciences Join Forces to Fight Tasmanian Devil Disease | GenomeWeb
NEW YORK (GenomeWeb News) – Roche subsidiary 454 Life Sciences is collaborating with researchers at Cold Spring Harbor Laboratory to fight a mysterious disease afflicting one of Australia’s signature animals: the Tasmanian devil.
 
The CSHL project, led by Tasmanian native Elizabeth Murchison, a post-doctoral researcher, aims to understand the genetics of a fatal cancer ravaging wild Tasmanian devil populations. The team presented its research plan to visiting Tasmanian government officials last week.  
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.